Cargando…

Effects of the N-methyl-D-Aspartate receptor antagonist dextromethorphan on vibrotactile adaptation

BACKGROUND: Previous reports have demonstrated that short durations of vibrotactile stimuli (less than or equal to 2 sec) effectively and consistently modify both the perceptual response in humans as well as the neurophysiological response in somatosensory cortex. The change in cortical response wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Folger, Stephen E, Tannan, Vinay, Zhang, Zheng, Holden, Jameson K, Tommerdahl, Mark
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2553799/ https://www.ncbi.nlm.nih.gov/pubmed/18796147 http://dx.doi.org/10.1186/1471-2202-9-87

Ejemplares similares

Effect of N-Methyl-D-Aspartate Receptor Antagonist Dextromethorphan on Opioid Analgesia in Pediatric Intensive Care Unit
por: Naeem, Mohammed, et al.
Publicado: (2016)

Absence of stimulus-driven synchronization effects on sensory perception in autism: Evidence for local underconnectivity?
por: Tommerdahl, Mark, et al.
Publicado: (2008)

Percept of the duration of a vibrotactile stimulus is altered by changing its amplitude
por: Francisco, Eric M., et al.
Publicado: (2015)

A quantitative method for determining spatial discriminative capacity
por: Zhang, Zheng, et al.
Publicado: (2008)

Effects of stimulus-driven synchronization on sensory perception
por: Tommerdahl, Mark, et al.
Publicado: (2007)

Editorial: Enzymes Regulating the Homeostasis of Agonists and Antagonists of the N-Methyl D-Aspartate Receptors
por: Mozzarelli, Andrea, et al.
Publicado: (2019)

N-Methyl D-Aspartate Receptor Antagonist Kynurenic Acid Affects Human Cortical Development
por: Bagasrawala, Inseyah, et al.
Publicado: (2016)

Kappa opioid receptor antagonist and N-methyl-D-aspartate receptor antagonist affect dynorphin-induced spinal cord electrophysiologic impairment☆
por: Chen, Yu, et al.
Publicado: (2012)

Antagonist Properties of Conus parius Peptides on N-Methyl-D-Aspartate Receptors and Their Effects on CREB Signaling
por: Kunda, Shailaja, et al.
Publicado: (2013)

Reproducibility of flutter-range vibrotactile detection and discrimination thresholds
por: Mikkelsen, Mark, et al.
Publicado: (2020)

Anti-N-methyl-D-aspartate Receptor Encephalitis
por: Tanquary, Gregory, et al.
Publicado: (2019)

Visualizing the triheteromeric N-methyl-D-aspartate receptor subunit composition
por: Beesley, Stephen, et al.
Publicado: (2023)

Cocaine self-administration disrupted by the N-methyl-D-aspartate receptor antagonist ketamine: a randomized, crossover trial
por: Dakwar, E, et al.
Publicado: (2016)

Conventional Versus New Treatment: Comparing the Effects of Acetylcholinesterase Inhibitors and N-Methyl-D-Aspartate Receptor Antagonist With Aducanumab
por: Chin, Elysia, et al.
Publicado: (2022)

Response of SII cortex to ipsilateral, contralateral and bilateral flutter stimulation in the cat
por: Tommerdahl, Mark, et al.
Publicado: (2005)

Preclinical pharmacology and pharmacokinetics of CERC‐301, a GluN2B‐selective N‐methyl‐D‐aspartate receptor antagonist
por: Garner, Rachel, et al.
Publicado: (2015)

A vibrotactile behavioral battery for investigating somatosensory processing in children and adults
por: Puts, Nicolaas A.J., et al.
Publicado: (2013)

Pediatric anti-N methyl D aspartate receptor encephalitis
por: Suri, Vinit, et al.
Publicado: (2013)

Pediatric N-Methyl-D-Aspartate Receptor Autoimmune Encephalitis
por: Uvais, N. A.
Publicado: (2018)

Roles of N-Methyl-D-Aspartate Receptors (NMDARs) in Epilepsy
por: Chen, Shuang, et al.
Publicado: (2022)

Protein quality control of N-methyl-D-aspartate receptors
por: Benske, Taylor M., et al.
Publicado: (2022)

Symptomatic treatments of N-methyl-D-aspartate receptor encephalitis
por: Lee, Soon-Tae
Publicado: (2021)

Symptomatologic pathomechanism of N-methyl D-aspartate receptor encephalitis
por: Lee, Woo-Jin
Publicado: (2021)

Stimulus-dependent effects on tactile spatial acuity
por: Tannan, V, et al.
Publicado: (2005)

Using an experimental medicine model to understand the antidepressant potential of the N-Methyl-D-aspartic acid (NMDA) receptor antagonist memantine
por: Pringle, A, et al.
Publicado: (2012)

Infantile Anti-N-Methyl-D-Aspartate Receptor Encephalitis Post-SARS-CoV-2 Infection
por: Kaur, Prabhjot, et al.
Publicado: (2022)

Amplitude-dependency of response of SI cortex to flutter stimulation
por: Simons, Stephen B, et al.
Publicado: (2005)

Ionic permeability characteristics of the N-methyl-D-aspartate receptor channel
Publicado: (1994)

Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia
por: Weickert, C S, et al.
Publicado: (2013)

Long-term potentiation and the role of N-methyl-d-aspartate receptors
por: Volianskis, Arturas, et al.
Publicado: (2015)

Early Intervention for Psychosis with N-Methyl-D-Aspartate Receptor Modulators
por: Dong, Chao, et al.
Publicado: (2015)

Anti-N-Methyl-D-Aspartate Receptor Encephalitis in HIV Infection
por: Patarata, Eunice, et al.
Publicado: (2016)

ON or OFF?: Modulating the N-Methyl-D-Aspartate Receptor in Major Depression
por: Chan, Shi Yu, et al.
Publicado: (2017)

Paraneoplastic Anti-N-Methyl-D-Aspartic Acid Receptor Encephalitis
por: Niu, Chi, et al.
Publicado: (2017)

A case of anti-N-methyl-d-aspartate receptor encephalitis
por: Abdul Rashid, Anna Misyail, et al.
Publicado: (2020)

The Role of the N-Methyl-D-Aspartate Receptors in Social Behavior in Rodents
por: Zoicas, Iulia, et al.
Publicado: (2019)

Autoantibodies detection in anti-N-methyl-D-aspartate receptor encephalitis
por: Li, Jiayu, et al.
Publicado: (2021)

GluN2A and GluN2B N-Methyl-D-Aspartate Receptor (NMDARs) Subunits: Their Roles and Therapeutic Antagonists in Neurological Diseases
por: Ladagu, Amany Digal, et al.
Publicado: (2023)

Synergic induction of human periodontal ligament fibroblast cell death by nitric oxide and N-methyl-D-aspartic acid receptor antagonist
por: Seo, Taegun, et al.
Publicado: (2011)

Pursuing the Complexity of Alzheimer’s Disease: Discovery of Fluoren-9-Amines as Selective Butyrylcholinesterase Inhibitors and N-Methyl-d-Aspartate Receptor Antagonists
por: Konecny, Jan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b7ok3jjh4ma6ppges3n17r05pd